nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ocular cancer—peripheral nervous system neoplasm	0.171	0.348	CtDrD
Dactinomycin—ABCB1—peripheral nervous system neoplasm	0.138	1	CbGaD
Dactinomycin—skin cancer—peripheral nervous system neoplasm	0.0912	0.185	CtDrD
Dactinomycin—muscle cancer—peripheral nervous system neoplasm	0.0851	0.173	CtDrD
Dactinomycin—germ cell cancer—peripheral nervous system neoplasm	0.0764	0.155	CtDrD
Dactinomycin—sarcoma—peripheral nervous system neoplasm	0.0678	0.138	CtDrD
Dactinomycin—ABCC6—Cisplatin—peripheral nervous system neoplasm	0.0514	0.176	CbGbCtD
Dactinomycin—ABCC6—Etoposide—peripheral nervous system neoplasm	0.0505	0.173	CbGbCtD
Dactinomycin—ABCC6—Doxorubicin—peripheral nervous system neoplasm	0.0344	0.118	CbGbCtD
Dactinomycin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0255	0.0873	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0191	0.0655	CbGbCtD
Dactinomycin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0163	0.0557	CbGbCtD
Dactinomycin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0149	0.051	CbGbCtD
Dactinomycin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0109	0.0372	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0102	0.0348	CbGbCtD
Dactinomycin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0101	0.0347	CbGbCtD
Dactinomycin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00997	0.0341	CbGbCtD
Dactinomycin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00919	0.0315	CbGbCtD
Dactinomycin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00919	0.0315	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0068	0.0233	CbGbCtD
Dactinomycin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00392	0.0134	CbGbCtD
Dactinomycin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00366	0.0125	CbGbCtD
Dactinomycin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00359	0.0123	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00245	0.00839	CbGbCtD
Dactinomycin—ABCC6—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00137	1	CbGdCrCtD
Dactinomycin—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.00136	CcSEcCtD
Dactinomycin—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000103	0.00136	CcSEcCtD
Dactinomycin—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00135	CcSEcCtD
Dactinomycin—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.000103	0.00134	CcSEcCtD
Dactinomycin—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.00134	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000101	0.00132	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000101	0.00132	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.0001	0.00131	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.0001	0.00131	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00131	CcSEcCtD
Dactinomycin—Alopecia—Vincristine—peripheral nervous system neoplasm	9.99e-05	0.00131	CcSEcCtD
Dactinomycin—Stomatitis—Etoposide—peripheral nervous system neoplasm	9.95e-05	0.0013	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	9.89e-05	0.0013	CcSEcCtD
Dactinomycin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	9.64e-05	0.00126	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.00126	CcSEcCtD
Dactinomycin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	9.56e-05	0.00125	CcSEcCtD
Dactinomycin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	9.56e-05	0.00125	CcSEcCtD
Dactinomycin—Fatigue—Topotecan—peripheral nervous system neoplasm	9.56e-05	0.00125	CcSEcCtD
Dactinomycin—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	9.52e-05	0.00125	CcSEcCtD
Dactinomycin—Fatigue—Tretinoin—peripheral nervous system neoplasm	9.48e-05	0.00124	CcSEcCtD
Dactinomycin—Fatigue—Isotretinoin—peripheral nervous system neoplasm	9.48e-05	0.00124	CcSEcCtD
Dactinomycin—Pain—Topotecan—peripheral nervous system neoplasm	9.48e-05	0.00124	CcSEcCtD
Dactinomycin—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	9.48e-05	0.00124	CcSEcCtD
Dactinomycin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	9.44e-05	0.00124	CcSEcCtD
Dactinomycin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	9.44e-05	0.00124	CcSEcCtD
Dactinomycin—Pain—Isotretinoin—peripheral nervous system neoplasm	9.41e-05	0.00123	CcSEcCtD
Dactinomycin—Pain—Tretinoin—peripheral nervous system neoplasm	9.41e-05	0.00123	CcSEcCtD
Dactinomycin—Fatigue—Melphalan—peripheral nervous system neoplasm	9.36e-05	0.00123	CcSEcCtD
Dactinomycin—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.00122	CcSEcCtD
Dactinomycin—Pain—Melphalan—peripheral nervous system neoplasm	9.28e-05	0.00122	CcSEcCtD
Dactinomycin—Flushing—Cisplatin—peripheral nervous system neoplasm	9.28e-05	0.00122	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.00121	CcSEcCtD
Dactinomycin—Malaise—Alitretinoin—peripheral nervous system neoplasm	9.21e-05	0.00121	CcSEcCtD
Dactinomycin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	9.14e-05	0.0012	CcSEcCtD
Dactinomycin—Anaemia—Vincristine—peripheral nervous system neoplasm	9.1e-05	0.00119	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	9.07e-05	0.00119	CcSEcCtD
Dactinomycin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	9.06e-05	0.00119	CcSEcCtD
Dactinomycin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	9.06e-05	0.00119	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	8.99e-05	0.00118	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	8.99e-05	0.00118	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.00116	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.00116	CcSEcCtD
Dactinomycin—Alopecia—Cisplatin—peripheral nervous system neoplasm	8.83e-05	0.00116	CcSEcCtD
Dactinomycin—Leukopenia—Vincristine—peripheral nervous system neoplasm	8.81e-05	0.00115	CcSEcCtD
Dactinomycin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	8.77e-05	0.00115	CcSEcCtD
Dactinomycin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	8.77e-05	0.00115	CcSEcCtD
Dactinomycin—Erythema—Cisplatin—peripheral nervous system neoplasm	8.7e-05	0.00114	CcSEcCtD
Dactinomycin—Myalgia—Alitretinoin—peripheral nervous system neoplasm	8.7e-05	0.00114	CcSEcCtD
Dactinomycin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	8.7e-05	0.00114	CcSEcCtD
Dactinomycin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	8.7e-05	0.00114	CcSEcCtD
Dactinomycin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	8.7e-05	0.00114	CcSEcCtD
Dactinomycin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	8.7e-05	0.00114	CcSEcCtD
Dactinomycin—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	8.66e-05	0.00113	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.00113	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.00113	CcSEcCtD
Dactinomycin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	8.59e-05	0.00113	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.00112	CcSEcCtD
Dactinomycin—Flushing—Etoposide—peripheral nervous system neoplasm	8.5e-05	0.00111	CcSEcCtD
Dactinomycin—Myalgia—Vincristine—peripheral nervous system neoplasm	8.38e-05	0.0011	CcSEcCtD
Dactinomycin—Oedema—Alitretinoin—peripheral nervous system neoplasm	8.34e-05	0.00109	CcSEcCtD
Dactinomycin—Infection—Alitretinoin—peripheral nervous system neoplasm	8.28e-05	0.00108	CcSEcCtD
Dactinomycin—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.00108	CcSEcCtD
Dactinomycin—Chills—Etoposide—peripheral nervous system neoplasm	8.22e-05	0.00108	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.00108	CcSEcCtD
Dactinomycin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	8.17e-05	0.00107	CcSEcCtD
Dactinomycin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	8.16e-05	0.00107	CcSEcCtD
Dactinomycin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	8.1e-05	0.00106	CcSEcCtD
Dactinomycin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	8.1e-05	0.00106	CcSEcCtD
Dactinomycin—Alopecia—Etoposide—peripheral nervous system neoplasm	8.09e-05	0.00106	CcSEcCtD
Dactinomycin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	8.08e-05	0.00106	CcSEcCtD
Dactinomycin—Anaemia—Cisplatin—peripheral nervous system neoplasm	8.04e-05	0.00105	CcSEcCtD
Dactinomycin—Oedema—Vincristine—peripheral nervous system neoplasm	8.03e-05	0.00105	CcSEcCtD
Dactinomycin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	8e-05	0.00105	CcSEcCtD
Dactinomycin—Infection—Vincristine—peripheral nervous system neoplasm	7.98e-05	0.00105	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.00104	CcSEcCtD
Dactinomycin—Asthenia—Topotecan—peripheral nervous system neoplasm	7.96e-05	0.00104	CcSEcCtD
Dactinomycin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	7.95e-05	0.00104	CcSEcCtD
Dactinomycin—Asthenia—Tretinoin—peripheral nervous system neoplasm	7.89e-05	0.00103	CcSEcCtD
Dactinomycin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	7.89e-05	0.00103	CcSEcCtD
Dactinomycin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	7.87e-05	0.00103	CcSEcCtD
Dactinomycin—Malaise—Cisplatin—peripheral nervous system neoplasm	7.85e-05	0.00103	CcSEcCtD
Dactinomycin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	7.79e-05	0.00102	CcSEcCtD
Dactinomycin—Asthenia—Melphalan—peripheral nervous system neoplasm	7.79e-05	0.00102	CcSEcCtD
Dactinomycin—Anorexia—Vincristine—peripheral nervous system neoplasm	7.66e-05	0.001	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.001	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	7.6e-05	0.000995	CcSEcCtD
Dactinomycin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	7.59e-05	0.000994	CcSEcCtD
Dactinomycin—Lethargy—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000992	CcSEcCtD
Dactinomycin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	7.53e-05	0.000986	CcSEcCtD
Dactinomycin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	7.53e-05	0.000986	CcSEcCtD
Dactinomycin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	7.43e-05	0.000973	CcSEcCtD
Dactinomycin—Myalgia—Cisplatin—peripheral nervous system neoplasm	7.41e-05	0.000971	CcSEcCtD
Dactinomycin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	7.4e-05	0.000969	CcSEcCtD
Dactinomycin—Anaemia—Etoposide—peripheral nervous system neoplasm	7.37e-05	0.000965	CcSEcCtD
Dactinomycin—Discomfort—Cisplatin—peripheral nervous system neoplasm	7.32e-05	0.000959	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	7.32e-05	0.000959	CcSEcCtD
Dactinomycin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	7.25e-05	0.000949	CcSEcCtD
Dactinomycin—Malaise—Etoposide—peripheral nervous system neoplasm	7.19e-05	0.000942	CcSEcCtD
Dactinomycin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	7.19e-05	0.000941	CcSEcCtD
Dactinomycin—Leukopenia—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.000935	CcSEcCtD
Dactinomycin—Pain—Alitretinoin—peripheral nervous system neoplasm	7.13e-05	0.000934	CcSEcCtD
Dactinomycin—Oedema—Cisplatin—peripheral nervous system neoplasm	7.1e-05	0.00093	CcSEcCtD
Dactinomycin—Infection—Cisplatin—peripheral nervous system neoplasm	7.06e-05	0.000924	CcSEcCtD
Dactinomycin—Vomiting—Topotecan—peripheral nervous system neoplasm	7.05e-05	0.000924	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000918	CcSEcCtD
Dactinomycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	6.99e-05	0.000916	CcSEcCtD
Dactinomycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	6.99e-05	0.000916	CcSEcCtD
Dactinomycin—Rash—Topotecan—peripheral nervous system neoplasm	6.99e-05	0.000916	CcSEcCtD
Dactinomycin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	6.98e-05	0.000915	CcSEcCtD
Dactinomycin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	6.95e-05	0.000911	CcSEcCtD
Dactinomycin—Rash—Tretinoin—peripheral nervous system neoplasm	6.94e-05	0.000908	CcSEcCtD
Dactinomycin—Rash—Isotretinoin—peripheral nervous system neoplasm	6.94e-05	0.000908	CcSEcCtD
Dactinomycin—Fatigue—Vincristine—peripheral nervous system neoplasm	6.93e-05	0.000907	CcSEcCtD
Dactinomycin—Vomiting—Melphalan—peripheral nervous system neoplasm	6.9e-05	0.000904	CcSEcCtD
Dactinomycin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	6.87e-05	0.0009	CcSEcCtD
Dactinomycin—Pain—Vincristine—peripheral nervous system neoplasm	6.87e-05	0.0009	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000898	CcSEcCtD
Dactinomycin—Rash—Melphalan—peripheral nervous system neoplasm	6.85e-05	0.000897	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	6.82e-05	0.000893	CcSEcCtD
Dactinomycin—Anorexia—Cisplatin—peripheral nervous system neoplasm	6.77e-05	0.000887	CcSEcCtD
Dactinomycin—Discomfort—Etoposide—peripheral nervous system neoplasm	6.71e-05	0.000878	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000875	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000875	CcSEcCtD
Dactinomycin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	6.59e-05	0.000863	CcSEcCtD
Dactinomycin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	6.59e-05	0.000863	CcSEcCtD
Dactinomycin—Nausea—Topotecan—peripheral nervous system neoplasm	6.59e-05	0.000863	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	6.57e-05	0.00086	CcSEcCtD
Dactinomycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	6.53e-05	0.000856	CcSEcCtD
Dactinomycin—Nausea—Tretinoin—peripheral nervous system neoplasm	6.53e-05	0.000856	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	6.47e-05	0.000848	CcSEcCtD
Dactinomycin—Infection—Etoposide—peripheral nervous system neoplasm	6.46e-05	0.000847	CcSEcCtD
Dactinomycin—Nausea—Melphalan—peripheral nervous system neoplasm	6.45e-05	0.000845	CcSEcCtD
Dactinomycin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.00084	CcSEcCtD
Dactinomycin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	6.37e-05	0.000835	CcSEcCtD
Dactinomycin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	6.35e-05	0.000832	CcSEcCtD
Dactinomycin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	6.35e-05	0.000832	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.00083	CcSEcCtD
Dactinomycin—Anorexia—Etoposide—peripheral nervous system neoplasm	6.2e-05	0.000812	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.00081	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.00081	CcSEcCtD
Dactinomycin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	6.17e-05	0.000809	CcSEcCtD
Dactinomycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	6.14e-05	0.000805	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000798	CcSEcCtD
Dactinomycin—Pain—Cisplatin—peripheral nervous system neoplasm	6.07e-05	0.000796	CcSEcCtD
Dactinomycin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000786	CcSEcCtD
Dactinomycin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	5.98e-05	0.000783	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000777	CcSEcCtD
Dactinomycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	5.92e-05	0.000775	CcSEcCtD
Dactinomycin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.85e-05	0.000767	CcSEcCtD
Dactinomycin—Asthenia—Vincristine—peripheral nervous system neoplasm	5.76e-05	0.000755	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000754	CcSEcCtD
Dactinomycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.7e-05	0.000747	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000743	CcSEcCtD
Dactinomycin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.66e-05	0.000741	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000738	CcSEcCtD
Dactinomycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.62e-05	0.000735	CcSEcCtD
Dactinomycin—Fatigue—Etoposide—peripheral nervous system neoplasm	5.61e-05	0.000735	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.00073	CcSEcCtD
Dactinomycin—Pain—Etoposide—peripheral nervous system neoplasm	5.56e-05	0.000729	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000727	CcSEcCtD
Dactinomycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.5e-05	0.00072	CcSEcCtD
Dactinomycin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.36e-05	0.000702	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000699	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000697	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.32e-05	0.000697	CcSEcCtD
Dactinomycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.3e-05	0.000694	CcSEcCtD
Dactinomycin—Rash—Alitretinoin—peripheral nervous system neoplasm	5.26e-05	0.000689	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000687	CcSEcCtD
Dactinomycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.23e-05	0.000685	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.000676	CcSEcCtD
Dactinomycin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.14e-05	0.000674	CcSEcCtD
Dactinomycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.14e-05	0.000674	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000673	CcSEcCtD
Dactinomycin—Vomiting—Vincristine—peripheral nervous system neoplasm	5.11e-05	0.000669	CcSEcCtD
Dactinomycin—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.1e-05	0.000668	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000667	CcSEcCtD
Dactinomycin—Rash—Vincristine—peripheral nervous system neoplasm	5.06e-05	0.000663	CcSEcCtD
Dactinomycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.95e-05	0.000649	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000647	CcSEcCtD
Dactinomycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.86e-05	0.000637	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000636	CcSEcCtD
Dactinomycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.79e-05	0.000628	CcSEcCtD
Dactinomycin—Nausea—Vincristine—peripheral nervous system neoplasm	4.77e-05	0.000625	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000624	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.75e-05	0.000622	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000618	CcSEcCtD
Dactinomycin—Asthenia—Etoposide—peripheral nervous system neoplasm	4.67e-05	0.000612	CcSEcCtD
Dactinomycin—Chills—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000603	CcSEcCtD
Dactinomycin—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.54e-05	0.000594	CcSEcCtD
Dactinomycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.52e-05	0.000592	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000588	CcSEcCtD
Dactinomycin—Rash—Cisplatin—peripheral nervous system neoplasm	4.48e-05	0.000587	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000585	CcSEcCtD
Dactinomycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.45e-05	0.000583	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000578	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000558	CcSEcCtD
Dactinomycin—Nausea—Cisplatin—peripheral nervous system neoplasm	4.22e-05	0.000553	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.2e-05	0.00055	CcSEcCtD
Dactinomycin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000543	CcSEcCtD
Dactinomycin—Vomiting—Etoposide—peripheral nervous system neoplasm	4.14e-05	0.000542	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000542	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000541	CcSEcCtD
Dactinomycin—Rash—Etoposide—peripheral nervous system neoplasm	4.1e-05	0.000537	CcSEcCtD
Dactinomycin—Malaise—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000528	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000524	CcSEcCtD
Dactinomycin—Nausea—Etoposide—peripheral nervous system neoplasm	3.87e-05	0.000506	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000503	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000501	CcSEcCtD
Dactinomycin—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.81e-05	0.000498	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000492	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000488	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000485	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000478	CcSEcCtD
Dactinomycin—Infection—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000475	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000468	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.52e-05	0.000461	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000456	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000455	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000442	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000439	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000435	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000433	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000421	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000415	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000412	CcSEcCtD
Dactinomycin—Pain—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000409	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000403	CcSEcCtD
Dactinomycin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000394	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000391	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000384	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000381	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000378	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000378	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000378	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000364	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000362	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000352	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000349	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000349	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000343	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000327	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000326	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000317	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.32e-05	0.000304	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000302	CcSEcCtD
Dactinomycin—Rash—Epirubicin—peripheral nervous system neoplasm	2.3e-05	0.000301	CcSEcCtD
Dactinomycin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.17e-05	0.000284	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.15e-05	0.000281	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.13e-05	0.000279	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2e-05	0.000263	CcSEcCtD
